Marie Hoarau

Dr. Marie Hoarau

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2017 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MHMarie Hoarau
Marie Hoarau
SBSomayesadat Badieyan
Somayesadat Badieyan
EME. Neil G. Marsh
E. Neil G. Marsh
Interactions between immobilized enzymes and supporting surfaces are complex and context-dependent and can significantly alter enzyme structure, stability and activity.

1 February 2016 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
MHMarie Hoarau
Marie Hoarau
CHChristelle Hureau
Christelle Hureau
EGEmmanuel Gras
Emmanuel Gras
PFPeter Faller
Peter Faller

1 May 2016 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
MJMichael R. Jones
Michael R. Jones
CDChristine Dyrager
Christine Dyrager
MHMarie Hoarau
Marie Hoarau
KKKyle J. Korshavn
Kyle J. Korshavn
MLMi Hee Lim
Mi Hee Lim
TSTim Storr
Tim Storr

24 July 2023 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MHMarie Hoarau
Marie Hoarau
PSPatpanat Sermmai
Patpanat Sermmai
TVThaveechai Varatthan
Thaveechai Varatthan
RTRatthiya Thiabma
Ratthiya Thiabma
TJTararat Jantra
Tararat Jantra
SKSumalee Kamchonwongpaisan
Sumalee Kamchonwongpaisan
The screen of a fragment library identified hydrophobic fragments binding to drug resistant PfDHFR active site. Lead design using fragment-linking strategy yielded compounds with nM antimalarial activity, no cytotoxicity and drug-like properties.

17 August 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MHMarie Hoarau
Marie Hoarau
YMYannick Malbert
Yannick Malbert
RIRomain Irague
Romain Irague
CHChristelle Hureau
Christelle Hureau
Peter FallerPeter Faller
Peter Faller
MRMagali Remaud-Simeon
Magali Remaud-Simeon
An improved production and purification method for Alzheimer’s disease related methionine-modified amyloid-β 1–40 and 1–42 peptides is proposed, taking advantage of the formation of inclusion body in Escherichia coli. A Thioflavin-S assay was set-up to evaluate inclusion body formation during growth and optimize culture conditions for amyloid-β peptides production. A simple and fast purification protocol including first the isolation of the inclusion bodies and second, two cycles of high pH denaturation/ neutralization combined with an ultrafiltration step on 30-kDa cut-off membrane was established. Special attention was paid to purity monitoring based on a rational combination of UV spectrophotometry and SDS-PAGE analyses at the various stages of the process. It revealed that this chromatography-free protocol affords good yield of high quality peptides in term of purity. The resulting peptides were fully characterized and are appropriate models for highly reproducible in vitro aggregation studies.

27 August 2019 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
MHMarie Hoarau
Marie Hoarau
KKKarl J. Koebke
Karl J. Koebke
ZCZhan Chen
Zhan Chen
EME. Neil G. Marsh
E. Neil G. Marsh
The design of metal-binding sites in proteins that combine high affinity with high selectivity for the desired metal ion remains a challenging goal. Recently, a protein designed to display femtomolar affinity for UO22+, dubbed “Super Uranyl-binding Protein” (SUP), was described, with potential applications for removing UO22+ in water. Although it discriminated most metal ions present in seawater, the protein showed a surprisingly high affinity for Cu2+ ions. Here, we have investigated Cu2+ binding to SUP using a combination of electron paramagnetic resonance, fluorescence and circular dichroism spectroscopies. Our results provide evidence for two Cu2+ binding sites on SUP that are distinct from the UO22+ binding site, but one of which interferes with UO22+ binding. They further suggest that in solution the protein's secondary structure changes significantly in response to binding UO22+; in contrast, the crystal structures of the apo- and holo-protein are almost superimposable. These results provide insights for further improving the selectivity of SUP for UO22+, paving the way toward protein-based biomaterials for decontamination and/or recovery of uranium.